BR0207933A - Mutantes de interleucina-18, sua produção e uso - Google Patents
Mutantes de interleucina-18, sua produção e usoInfo
- Publication number
- BR0207933A BR0207933A BR0207933-0A BRPI0207933A BR0207933A BR 0207933 A BR0207933 A BR 0207933A BR PI0207933 A BRPI0207933 A BR PI0207933A BR 0207933 A BR0207933 A BR 0207933A
- Authority
- BR
- Brazil
- Prior art keywords
- mutants
- interleukin
- production
- molecule
- wild type
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27432701P | 2001-03-08 | 2001-03-08 | |
US60/274,327 | 2001-03-08 | ||
PCT/IB2002/002344 WO2002101049A2 (en) | 2001-03-08 | 2002-03-08 | Interleukin-18 mutants, their production and use |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0207933A true BR0207933A (pt) | 2004-03-02 |
BRPI0207933B1 BRPI0207933B1 (pt) | 2020-11-24 |
BRPI0207933B8 BRPI0207933B8 (pt) | 2021-05-25 |
Family
ID=23047735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0207933-0 BRPI0207933B8 (pt) | 2001-03-08 | 2002-03-08 | polipeptídeo mutante de interleucina-18 e composição farmacêutica |
Country Status (19)
Country | Link |
---|---|
US (2) | US7524488B2 (pt) |
EP (1) | EP1392830B1 (pt) |
JP (1) | JP2004530432A (pt) |
KR (1) | KR100862136B1 (pt) |
CN (1) | CN100503829C (pt) |
AT (1) | ATE315647T1 (pt) |
AU (1) | AU2002324249B2 (pt) |
BR (1) | BRPI0207933B8 (pt) |
CA (1) | CA2438851C (pt) |
DE (1) | DE60208692T2 (pt) |
DK (1) | DK1392830T3 (pt) |
EA (1) | EA005769B1 (pt) |
ES (1) | ES2251610T3 (pt) |
HK (1) | HK1084151A1 (pt) |
IL (2) | IL157800A0 (pt) |
MX (1) | MXPA03008110A (pt) |
SI (1) | SI1392830T1 (pt) |
UA (1) | UA79235C2 (pt) |
WO (1) | WO2002101049A2 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004031341D1 (de) | 2003-07-21 | 2011-03-24 | Transgene Sa | Multifunktionelle cytokine |
AU2004263274B2 (en) * | 2003-07-21 | 2009-11-05 | Transgene S.A. | Novel multifunctional cytokines |
AU2004291341B2 (en) * | 2003-11-05 | 2010-08-05 | Ares Trading S.A. | Process for the purification of IL-18 binding protein |
US7557084B2 (en) * | 2004-03-31 | 2009-07-07 | Regeneron Pharmaceuticals, Inc. | IL-18 specific polypeptides and therapeutic uses thereof |
PT1885753E (pt) | 2005-06-03 | 2011-10-06 | Ares Trading Sa | Produção de proteína recombinante de ligação a il-18 |
CA2610804C (en) | 2005-06-10 | 2013-11-19 | Ares Trading S.A. | Process for the purification of il-18 binding protein |
CN101177454B (zh) * | 2007-05-09 | 2010-09-22 | 郑骏年 | Il-18突变体多肽及制备及用途 |
WO2012078936A2 (en) * | 2010-12-10 | 2012-06-14 | Glaxosmithkline Llc | Methods to produce a purified peptide chain fraction |
US20190070262A1 (en) * | 2017-09-06 | 2019-03-07 | Yale University | Interleukin-18 variants and methods of use |
JP2021170968A (ja) * | 2020-04-22 | 2021-11-01 | 国立大学法人 長崎大学 | マウスil−18の製造方法及びそのための組換えdna |
IL300638A (en) * | 2020-08-19 | 2023-04-01 | Bright Peak Therapeutics | Modified IL-18 polypeptides and uses thereof |
IL302517A (en) | 2020-11-02 | 2023-07-01 | Simcha Il 18 Inc | Variants of interleukin-18 and methods of use |
EP4293039A1 (en) * | 2021-02-10 | 2023-12-20 | Nagasaki University | Novel human interleukin-18 variant and use therefor |
US20230146665A1 (en) | 2021-07-27 | 2023-05-11 | Xencor, Inc. | Il-18-fc fusion proteins |
JP2023024168A (ja) | 2021-08-06 | 2023-02-16 | 国立大学法人 長崎大学 | がんの治療剤 |
WO2023056193A2 (en) * | 2021-09-29 | 2023-04-06 | Chimera Bioengineering, Inc. | Il-18 variants and uses thereof |
WO2023118497A1 (en) * | 2021-12-22 | 2023-06-29 | Pieris Pharmaceuticals Gmbh | Novel il-18 variants |
US20240116997A1 (en) | 2022-02-23 | 2024-04-11 | Bright Peak Therapeutics Ag | Activatable il-18 polypeptides |
WO2023161854A1 (en) * | 2022-02-23 | 2023-08-31 | Bright Peak Therapeutics Ag | Immune antigen specific il-18 immunocytokines and uses thereof |
US20230357342A1 (en) * | 2022-02-23 | 2023-11-09 | Bright Peak Therapeutics Ag | Modified il-18 polypeptides |
WO2024044780A1 (en) * | 2022-08-26 | 2024-02-29 | Sutro Biopharma, Inc. | Interleukin-18 variants and uses thereof |
US20240166705A1 (en) | 2022-11-07 | 2024-05-23 | Xencor, Inc. | Il18-fc fusion proteins |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4024366B2 (ja) * | 1996-11-29 | 2007-12-19 | 株式会社林原生物化学研究所 | ポリペプチド |
TWI227136B (en) * | 1998-05-21 | 2005-02-01 | Smithkline Beecham Corp | Novel pharmaceutical composition for the prevention and/or treatment of cancer |
IL129427A0 (en) | 1999-04-13 | 2000-02-17 | Yeda Res & Dev | Preparation of biologically active molecules |
-
2002
- 2002-03-08 AU AU2002324249A patent/AU2002324249B2/en not_active Expired
- 2002-03-08 KR KR1020037011581A patent/KR100862136B1/ko active IP Right Grant
- 2002-03-08 SI SI200230280T patent/SI1392830T1/sl unknown
- 2002-03-08 EP EP02758668A patent/EP1392830B1/en not_active Expired - Lifetime
- 2002-03-08 US US10/094,153 patent/US7524488B2/en not_active Expired - Lifetime
- 2002-03-08 MX MXPA03008110A patent/MXPA03008110A/es active IP Right Grant
- 2002-03-08 CA CA2438851A patent/CA2438851C/en not_active Expired - Lifetime
- 2002-03-08 JP JP2003503799A patent/JP2004530432A/ja active Pending
- 2002-03-08 ES ES02758668T patent/ES2251610T3/es not_active Expired - Lifetime
- 2002-03-08 EA EA200300987A patent/EA005769B1/ru not_active IP Right Cessation
- 2002-03-08 IL IL15780002A patent/IL157800A0/xx unknown
- 2002-03-08 WO PCT/IB2002/002344 patent/WO2002101049A2/en active IP Right Grant
- 2002-03-08 DE DE60208692T patent/DE60208692T2/de not_active Expired - Lifetime
- 2002-03-08 BR BRPI0207933-0 patent/BRPI0207933B8/pt not_active IP Right Cessation
- 2002-03-08 DK DK02758668T patent/DK1392830T3/da active
- 2002-03-08 AT AT02758668T patent/ATE315647T1/de active
- 2002-03-08 CN CNB02809803XA patent/CN100503829C/zh not_active Expired - Lifetime
- 2002-08-03 UA UA2003109084A patent/UA79235C2/uk unknown
-
2003
- 2003-09-08 IL IL157800A patent/IL157800A/en unknown
-
2006
- 2006-06-06 HK HK06106439.0A patent/HK1084151A1/xx not_active IP Right Cessation
-
2009
- 2009-03-16 US US12/404,458 patent/US7875709B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK1392830T3 (da) | 2006-05-08 |
CN100503829C (zh) | 2009-06-24 |
CA2438851A1 (en) | 2002-12-19 |
EP1392830B1 (en) | 2006-01-11 |
AU2002324249B2 (en) | 2007-04-05 |
DE60208692T2 (de) | 2006-07-13 |
ES2251610T3 (es) | 2006-05-01 |
IL157800A (en) | 2009-08-03 |
JP2004530432A (ja) | 2004-10-07 |
DE60208692D1 (de) | 2006-04-06 |
EP1392830A2 (en) | 2004-03-03 |
EA200300987A1 (ru) | 2004-02-26 |
US7524488B2 (en) | 2009-04-28 |
US7875709B2 (en) | 2011-01-25 |
SI1392830T1 (sl) | 2006-06-30 |
KR20030088448A (ko) | 2003-11-19 |
WO2002101049A2 (en) | 2002-12-19 |
MXPA03008110A (es) | 2003-12-12 |
US20090286855A1 (en) | 2009-11-19 |
ATE315647T1 (de) | 2006-02-15 |
US20020169291A1 (en) | 2002-11-14 |
IL157800A0 (en) | 2004-03-28 |
UA79235C2 (en) | 2007-06-11 |
CN1764723A (zh) | 2006-04-26 |
BRPI0207933B8 (pt) | 2021-05-25 |
CA2438851C (en) | 2011-07-26 |
HK1084151A1 (en) | 2006-07-21 |
BRPI0207933B1 (pt) | 2020-11-24 |
WO2002101049A3 (en) | 2003-12-18 |
EA005769B1 (ru) | 2005-06-30 |
KR100862136B1 (ko) | 2008-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0207933A (pt) | Mutantes de interleucina-18, sua produção e uso | |
BR0314814A (pt) | Variantes otimizadas de fc e métodos para sua geração | |
RS50477B (sr) | Anti-il-12 antitela, kompozicije, metode i njihove upotrebe | |
WO2001064835A8 (en) | Novel nucleic acids and polypeptides | |
EA200300464A1 (ru) | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ | |
ATE347057T1 (de) | Federelement | |
ID23374A (id) | Halogenopirimidin | |
ATE304866T1 (de) | Chelatorkonjugate mit verbesserten eigenschaften | |
DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
WO2001064834A8 (en) | Novel nucleic acids and polypeptides | |
WO2004055117A3 (de) | Carboxamid-substituierte farbstoffe für analytische anwendungen | |
DE60109430D1 (de) | An entzündlichen darmerkrankungen beteiligte gene und deren verwendung | |
DE69935782D1 (de) | Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna | |
DK1363944T3 (da) | Höjaffinitetsantagonister for ELR-CXC-kemokiner | |
SG146640A1 (en) | Isolated photoprotein mtclytin, and use thereof | |
CY1109904T1 (el) | Προαγωγεας της il-18bp, η παρασκευη και χρηση του | |
AU2003259750A1 (en) | Methods and compositions for targeting secretory lysosomes | |
ES2192034T3 (es) | Feniluracilos substituidos con efecto herbicida. | |
MXPA05007793A (es) | Composiciones de nucleotidos enlazados con alquilo. | |
WO2005057486A3 (en) | Protein engineering with analogous contact environments | |
DK1196607T3 (da) | Antibakterielt chlamysin B-protein, gen kodende derfor samt ekspressionssystem | |
ATE372788T1 (de) | Kontrastmittel bestehend aus geometrisch hochgeordneten proteinen für die medizinische diagnostik | |
ATE405668T1 (de) | Exopolysaccharidproduktion | |
WO2001064840A8 (en) | Novel bone marrow nucleic acids and polypeptides | |
DK0858465T3 (da) | Protein med antitumorvirkning. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25G | Requested change of headquarter approved |
Owner name: ARES TRADING S.A. (CH) Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDO NA PETICAO NO 055209/RJ DE 27/09/2004. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/11/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/03/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 21A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2713 DE 03-01-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |